Glenmark Pharmaceuticals U.S. > News

News

Press Releases

Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.

Glenmark receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP

October 25, 2016

Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP

October 25, 2016

Glenmark receives ANDA approval for Diclofenac Sodium Gel, 3%

September 14, 2016

Glenmark Pharmaceuticals receives ANDA approval for Diclofenac Sodium Gel, 3%

September 14, 2016

Glenmark receives ANDA approval for Lidocaine Ointment USP, 5%

September 13, 2016

News

Search Result :-

Is an investigational new drug that has not been approved for commercial distribution in the United States.

October 25, 2016
Glenmark receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP

October 25, 2016
Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP

September 14, 2016
Glenmark receives ANDA approval for Diclofenac Sodium Gel, 3%

September 14, 2016
Glenmark Pharmaceuticals receives ANDA approval for Diclofenac Sodium Gel, 3%

September 13, 2016
Glenmark receives ANDA approval for Lidocaine Ointment USP, 5%

US Media Contact

For media inquiries only, please contact Corporate Communications.
uscomms@glenmarkpharma.com

Investor Relations

For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.

POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES 750mg RECALL REIMBURSEMENT POLICY

Over-the-counter (OTC)

ACCESSIBLE PRODUCTS

Who We Are

Injectables

OUR GROWING LINE